Larry Richardson, an award-winning obesity medicine physician with over 30 years of experience, our clinic focuses on sustainable solutions that transform your health
TB-500 10mg A synthetic fragment of Thymosin Beta-4 studied for its interaction with G-actin sequestration, angiogenesis pathway activity, and cell migration mechanisms in preclinical research
Medication-related weight change can also have more than one cause
WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use
The most common symptom of GERD is heartburn, a condition that 20 percent of American adults experience at least twice a week
The FDA's 2022 guidance on bulk drug substances explicitly named BPC-157 as a compound that does not meet the criteria for inclusion in compounded drug preparations under Section 503A and 503B of the Federal Food, Drug, and Cosmetic Act
